NuGen Syringe | Eastman Innovation Lab
Projects

NuGen Syringe

A Shot of Innovation with Eastman Tritan™ copolyester

Overview

When it comes to understanding medical markets, Eastman has a large amount of engineering and industry insights. For NuGen™ syringes, Eastman provided technical expertise to help DMC Medical to seamlessly bring its product to market.

“When developing the NuGen™ line, we looked for a material that provided the range of benefits necessary of such devices and demanded by the industry,” said Bryan Wixted, CEO, DMC Medical Ltd. “We found the answer in Eastman Tritan™ copolyester with the advantages it provides — in particular, being free of BPA — put DMC Medical at the leading edge of premium syringe development and supply.”

Tritan allows outstanding chemical and lipid resistance for frequent contact with substances, superior clarity to allow health care practitioners to easily see the syringe’s contents, and retention of color and functionality post-sterilization. The NuGen™ syringe line targets medical device and pharmaceutical companies that include syringes in custom kits or pre-filled with specific drugs.